Skip to main content
. 2019 Aug 2;9:701. doi: 10.3389/fonc.2019.00701

Table 2.

Androgen Deprivation Therapy (ADT) regimens and response rates.

Treatment regimen Response rate
First-line ADT (n = 20) 55%
 Leuprolide + Bicalutamide (n = 14) 5 CR, 4 PR, 4 PD, 1 Unknown
 Leuprolide (n = 1) 1 PD
 Bicalutamide (n = 2) 2 PR
 Enzalutamide (n = 3) 1 SD, 2 PD
Salvage ADT after 1st line ADT (n = 6) 16.7%
 Leuprolide + Bicalutamide (n = 2) 1 SD, 1 PD
 Leuprolide (n = 1) 1 CR
 Enzalutamide (n = 1) 1 SD
 Leuprolide + Abiraterone (n = 1) 1 SD
 Abiraterone (n = 1) 1 PD
Salvage ADT after 1st line Chemo (n = 6) 16.7%
Leuprolide + Bicalutamide (n = 2) 1 PR, 1 SD

CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.